Logo image of HLI

HOULIHAN LOKEY INC (HLI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:HLI - US4415931009 - Common Stock

175.37 USD
+0.43 (+0.25%)
Last: 12/3/2025, 1:25:17 PM
Fundamental Rating

6

Taking everything into account, HLI scores 6 out of 10 in our fundamental rating. HLI was compared to 238 industry peers in the Capital Markets industry. While HLI has a great profitability rating, there are some minor concerns on its financial health. HLI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make HLI suitable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HLI was profitable.
HLI had a positive operating cash flow in the past year.
In the past 5 years HLI has always been profitable.
In the past 5 years HLI always reported a positive cash flow from operatings.
HLI Yearly Net Income VS EBIT VS OCF VS FCFHLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

HLI's Return On Assets of 11.24% is amongst the best of the industry. HLI outperforms 92.44% of its industry peers.
HLI's Return On Equity of 18.98% is amongst the best of the industry. HLI outperforms 87.39% of its industry peers.
Looking at the Return On Invested Capital, with a value of 18.66%, HLI belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
HLI had an Average Return On Invested Capital over the past 3 years of 15.77%. This is significantly above the industry average of 6.95%.
The last Return On Invested Capital (18.66%) for HLI is above the 3 year average (15.77%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.24%
ROE 18.98%
ROIC 18.66%
ROA(3y)9.29%
ROA(5y)11.19%
ROE(3y)16.47%
ROE(5y)20.47%
ROIC(3y)15.77%
ROIC(5y)19.56%
HLI Yearly ROA, ROE, ROICHLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 16.62%, HLI is in line with its industry, outperforming 52.10% of the companies in the same industry.
HLI's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 23.62%, HLI perfoms like the industry average, outperforming 49.16% of the companies in the same industry.
HLI's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.62%
PM (TTM) 16.62%
GM N/A
OM growth 3Y-4.82%
OM growth 5Y3.29%
PM growth 3Y-4.63%
PM growth 5Y1.08%
GM growth 3YN/A
GM growth 5YN/A
HLI Yearly Profit, Operating, Gross MarginsHLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, HLI has more shares outstanding
Compared to 5 years ago, HLI has more shares outstanding
HLI has a better debt/assets ratio than last year.
HLI Yearly Shares OutstandingHLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
HLI Yearly Total Debt VS Total AssetsHLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

HLI has an Altman-Z score of 6.51. This indicates that HLI is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.51, HLI belongs to the best of the industry, outperforming 89.50% of the companies in the same industry.
There is no outstanding debt for HLI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.51
ROIC/WACCN/A
WACCN/A
HLI Yearly LT Debt VS Equity VS FCFHLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

HLI has a Current Ratio of 0.97. This is a bad value and indicates that HLI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.97, HLI is in line with its industry, outperforming 40.34% of the companies in the same industry.
HLI has a Quick Ratio of 0.97. This is a bad value and indicates that HLI is not financially healthy enough and could expect problems in meeting its short term obligations.
HLI has a Quick ratio (0.97) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
HLI Yearly Current Assets VS Current LiabilitesHLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

7

3. Growth

3.1 Past

HLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.62%, which is quite impressive.
Measured over the past years, HLI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.36% on average per year.
Looking at the last year, HLI shows a very strong growth in Revenue. The Revenue has grown by 21.01%.
Measured over the past years, HLI shows a quite strong growth in Revenue. The Revenue has been growing by 15.56% on average per year.
EPS 1Y (TTM)46.62%
EPS 3Y-4.01%
EPS 5Y14.36%
EPS Q2Q%26.03%
Revenue 1Y (TTM)21.01%
Revenue growth 3Y1.72%
Revenue growth 5Y15.56%
Sales Q2Q%14.7%

3.2 Future

Based on estimates for the next years, HLI will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.38% on average per year.
HLI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.08% yearly.
EPS Next Y26.8%
EPS Next 2Y19.49%
EPS Next 3Y16.38%
EPS Next 5YN/A
Revenue Next Year15.49%
Revenue Next 2Y14.57%
Revenue Next 3Y13.08%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HLI Yearly Revenue VS EstimatesHLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
HLI Yearly EPS VS EstimatesHLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.14, HLI is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of HLI indicates a slightly more expensive valuation: HLI is more expensive than 63.03% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, HLI is valued at the same level.
With a Price/Forward Earnings ratio of 19.56, HLI is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as HLI.
The average S&P500 Price/Forward Earnings ratio is at 36.22. HLI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.14
Fwd PE 19.56
HLI Price Earnings VS Forward Price EarningsHLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

HLI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HLI is cheaper than 75.63% of the companies in the same industry.
HLI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HLI is cheaper than 62.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.68
EV/EBITDA 17.24
HLI Per share dataHLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

HLI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HLI has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HLI's earnings are expected to grow with 16.38% in the coming years.
PEG (NY)0.86
PEG (5Y)1.61
EPS Next 2Y19.49%
EPS Next 3Y16.38%

5

5. Dividend

5.1 Amount

HLI has a Yearly Dividend Yield of 1.37%. Purely for dividend investing, there may be better candidates out there.
HLI's Dividend Yield is slightly below the industry average, which is at 8.39.
Compared to an average S&P500 Dividend Yield of 2.32, HLI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

On average, the dividend of HLI grows each year by 14.04%, which is quite nice.
HLI has been paying a dividend for at least 10 years, so it has a reliable track record.
HLI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)14.04%
Div Incr Years9
Div Non Decr Years9
HLI Yearly Dividends per shareHLI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

39.81% of the earnings are spent on dividend by HLI. This is a low number and sustainable payout ratio.
The dividend of HLI is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP39.81%
EPS Next 2Y19.49%
EPS Next 3Y16.38%
HLI Yearly Income VS Free CF VS DividendHLI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
HLI Dividend Payout.HLI Dividend Payout, showing the Payout Ratio.HLI Dividend Payout.PayoutRetained Earnings

HOULIHAN LOKEY INC

NYSE:HLI (12/3/2025, 1:25:17 PM)

175.37

+0.43 (+0.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)01-26 2026-01-26/amc
Inst Owners103.13%
Inst Owner Change-1.24%
Ins Owners0.13%
Ins Owner Change-0.42%
Market Cap12.29B
Revenue(TTM)2.57B
Net Income(TTM)426.54M
Analysts70
Price Target218.57 (24.63%)
Short Float %2.4%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly Dividend2.38
Dividend Growth(5Y)14.04%
DP39.81%
Div Incr Years9
Div Non Decr Years9
Ex-Date12-01 2025-12-01 (0.6)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.69%
Min EPS beat(2)7.04%
Max EPS beat(2)26.35%
EPS beat(4)4
Avg EPS beat(4)15.08%
Min EPS beat(4)7.04%
Max EPS beat(4)26.35%
EPS beat(8)8
Avg EPS beat(8)9.86%
EPS beat(12)10
Avg EPS beat(12)7.35%
EPS beat(16)14
Avg EPS beat(16)9.82%
Revenue beat(2)2
Avg Revenue beat(2)3.17%
Min Revenue beat(2)0.74%
Max Revenue beat(2)5.6%
Revenue beat(4)4
Avg Revenue beat(4)3.87%
Min Revenue beat(4)0.74%
Max Revenue beat(4)5.6%
Revenue beat(8)7
Avg Revenue beat(8)3.15%
Revenue beat(12)9
Avg Revenue beat(12)1.68%
Revenue beat(16)13
Avg Revenue beat(16)4.38%
PT rev (1m)3.32%
PT rev (3m)5.87%
EPS NQ rev (1m)-2.76%
EPS NQ rev (3m)-2.01%
EPS NY rev (1m)1.87%
EPS NY rev (3m)2.91%
Revenue NQ rev (1m)-2.1%
Revenue NQ rev (3m)-1.58%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)0.88%
Valuation
Industry RankSector Rank
PE 23.14
Fwd PE 19.56
P/S 4.79
P/FCF 15.68
P/OCF 15.03
P/B 5.47
P/tB 16.3
EV/EBITDA 17.24
EPS(TTM)7.58
EY4.32%
EPS(NY)8.97
Fwd EY5.11%
FCF(TTM)11.18
FCFY6.38%
OCF(TTM)11.66
OCFY6.65%
SpS36.62
BVpS32.07
TBVpS10.76
PEG (NY)0.86
PEG (5Y)1.61
Graham Number73.95
Profitability
Industry RankSector Rank
ROA 11.24%
ROE 18.98%
ROCE 25.39%
ROIC 18.66%
ROICexc 30.44%
ROICexgc N/A
OM 23.62%
PM (TTM) 16.62%
GM N/A
FCFM 30.54%
ROA(3y)9.29%
ROA(5y)11.19%
ROE(3y)16.47%
ROE(5y)20.47%
ROIC(3y)15.77%
ROIC(5y)19.56%
ROICexc(3y)27.01%
ROICexc(5y)39.46%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.46%
ROCE(5y)26.61%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.39%
ROICexc growth 5Y3.92%
OM growth 3Y-4.82%
OM growth 5Y3.29%
PM growth 3Y-4.63%
PM growth 5Y1.08%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 65.84%
Cap/Sales 1.32%
Interest Coverage 250
Cash Conversion 124.35%
Profit Quality 183.7%
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 6.51
F-Score9
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)139.05%
Cap/Depr(5y)105.57%
Cap/Sales(3y)2.65%
Cap/Sales(5y)1.85%
Profit Quality(3y)109.81%
Profit Quality(5y)135.31%
High Growth Momentum
Growth
EPS 1Y (TTM)46.62%
EPS 3Y-4.01%
EPS 5Y14.36%
EPS Q2Q%26.03%
EPS Next Y26.8%
EPS Next 2Y19.49%
EPS Next 3Y16.38%
EPS Next 5YN/A
Revenue 1Y (TTM)21.01%
Revenue growth 3Y1.72%
Revenue growth 5Y15.56%
Sales Q2Q%14.7%
Revenue Next Year15.49%
Revenue Next 2Y14.57%
Revenue Next 3Y13.08%
Revenue Next 5YN/A
EBIT growth 1Y40.12%
EBIT growth 3Y-3.18%
EBIT growth 5Y19.36%
EBIT Next Year40.71%
EBIT Next 3Y23.18%
EBIT Next 5YN/A
FCF growth 1Y201.72%
FCF growth 3Y3.58%
FCF growth 5Y24.82%
OCF growth 1Y146.55%
OCF growth 3Y4.83%
OCF growth 5Y24.15%

HOULIHAN LOKEY INC / HLI FAQ

What is the ChartMill fundamental rating of HOULIHAN LOKEY INC (HLI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to HLI.


Can you provide the valuation status for HOULIHAN LOKEY INC?

ChartMill assigns a valuation rating of 4 / 10 to HOULIHAN LOKEY INC (HLI). This can be considered as Fairly Valued.


How profitable is HOULIHAN LOKEY INC (HLI) stock?

HOULIHAN LOKEY INC (HLI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for HLI stock?

The Price/Earnings (PE) ratio for HOULIHAN LOKEY INC (HLI) is 23.14 and the Price/Book (PB) ratio is 5.47.


Can you provide the financial health for HLI stock?

The financial health rating of HOULIHAN LOKEY INC (HLI) is 6 / 10.